Model Including Polygenic Risk, Polysocial Score Improves CHD Risk Prediction

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Dec 12, 2024.

By Elana Gotkine HealthDay Reporter

THURSDAY, Dec. 12, 2024 -- A prediction model incorporating a polygenic risk score (PRS) and polysocial score (PSS), including social determinants of health and lifestyle-psychological factors, improves performance of clinical risk calculators for coronary heart disease (CHD), according to a study published online Dec. 10 in the Annals of Internal Medicine.

Mohammadreza Naderian, M.D., M.P.H., from the Mayo Clinic in Rochester, Minnesota, and colleagues developed and evaluated a prediction model that incorporated a PRS and PSS to improve CHD risk prediction among U.K. Biobank participants recruited from 2006 to 2010.

The researchers found that the hazard ratios were 1.43 and 1.59 for one standard deviation increase in PSSCHD and PRSCHD, respectively, among 388,224 participants. Compared with White persons, non-White persons had higher PSSCHD. Both independent and additive effects were seen for PSSCHD and PRSCHD on CHD. Overall, 12 percent of participants were reclassified at a 10-year CHD risk threshold of 7.5 percent by adding PSSCHD and PRSCHD to pooled cohort equations (PCE), with the risk for CHD 1.86 times higher in the up- versus down-reclassified persons; superior performance was observed compared with PCE as reflected by improved net benefit while maintaining good calibration relative to the clinical risk calculators. When incorporating PSSCHD and PRSCHD into Predicting Risk of cardiovascular disease EVENTs and QRISK3 measures, the results were similar.

"Our findings support the integration of PRS, social determinants of health, and lifestyle-psychological factors in CHD risk equations and have implications for measures at the population level to reduce the burden of CHD as well as at the individual level to improve risk prediction of CHD," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-12-13 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords